Gain is a Maryland-based development-stage biopharmaceutical company that develops novel therapies for the treatment of genetic and neurodegenerative diseases.
Business Model:
Revenue: $210.7k
Employees: 11-50
Address: 4800 Hampden Lane
City: Bethesda
State: MD
Zip: 20814
Country: US
Gain is a Maryland-based development-stage biopharmaceutical company that develops novel therapies for the treatment of genetic and neurodegenerative diseases.
Contact Phone:
+13015001556
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
3/18/2021
IPO Valuation:
$129M
Ticker Symbol:
GANX
IPO Price:
$11/share
Amount Raised:
$40M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2019 | Grant | 3 | $1.6M |
Horizon 2020 Eurostars InnoSuisse Horizon 2020 Eurostars InnoSuisse |
7/2020 | Series B | $10M | 2/2019 | Series A | $2.8M |
TiVenture SA Helsinn Investment Fund S.A. |
2/2019 | Series A | 3 | $2.8M |
VitaTech S.A 3B Future Health Fund TiVentures 3B Future Health Fund TiVentures VitaTech S.A VitaTech S.A 3B Future Health Fund TiVentures 3B Future Health Fund TiVentures VitaTech S.A |
3/2021 | IPO | $40M | 7/2019 | Grant | $1.6M |
Eurostars |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|